JPMorgan Europe Research Enhanced Index Equity Active (LON:JREE)
London · Delayed Price · Currency is GBP · Price in EUR 51.77
-0.26 (-0.50%)
Apr 28, 2026, 3:02 PM GMT
18.34% (1Y)
| Assets | 2.29B |
| Expense Ratio | 0.25% |
| PE Ratio | 10.22 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +18.94% |
| Volume | 118,098 |
| Open | 52.07 |
| Previous Close | 52.03 |
| Day's Range | 51.65 - 52.18 |
| 52-Week Low | 43.90 |
| 52-Week High | 54.43 |
| Beta | 0.70 |
| Holdings | 156 |
| Inception Date | Oct 10, 2018 |
About JREE
The Sub-Fund aims to achieve a long-term return in excess of MSCI Europe Index (Total Return Net) (the "Benchmark") by actively investing primarily in a portfolio of European companies.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol JREE
Provider JPMorgan
Performance
JREE had a total return of 18.94% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.66%.
Top 10 Holdings
23.57% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.41% |
| AstraZeneca PLC | AZN | 2.75% |
| HSBC Holdings plc | HSBA | 2.20% |
| Nestlé S.A. | NESN | 2.19% |
| Shell plc | SHEL | 2.16% |
| Roche Holding AG | ROC1.L | 2.14% |
| Novartis AG | NOVN | 2.07% |
| Siemens Aktiengesellschaft | SIE | 1.99% |
| Allianz SE | ALV | 1.91% |
| Banco Santander, S.A. | SAN | 1.75% |